Related Experiment Video
Updated: Apr 15, 2026

06:34
Author Spotlight: Stimulation-Based Approach to Improve Cerebral Blood Flow in Alzheimer's Model
Published on: June 2, 2023
2.0K
Deep Brain Stimulation Influences Brain Structure in Alzheimer's Disease
Tejas Sankar1, M Mallar Chakravarty2, Agustin Bescos3
1Division of Neurosurgery, University of Alberta, Edmonton, Alberta, Canada.
Brain Stimulation
|March 28, 2015
Summary
Deep Brain Stimulation (DBS) of the fornix may slow brain atrophy in Alzheimer's Disease (AD). Some patients showed increased hippocampal volume, suggesting DBS could alter neurodegeneration progression.
Area of Science:
- Neuroscience
- Neurology
- Medical Technology
Background:
- Deep Brain Stimulation (DBS) modulates brain circuits for neurological disorders.
- Current evidence does not show DBS counteracting neurodegeneration.
Purpose of the Study:
- Investigate if fornix DBS affects brain structure in Alzheimer's Disease (AD).
- Hypothesize that DBS can influence structural changes in AD patients.
Main Methods:
- Structural MRI assessed hippocampal, fornix, and mammillary body volume changes over one year in six AD patients receiving DBS.
- Deformation-based morphometry identified whole-brain structural changes.
- Volumetric changes were correlated with hippocampal metabolism and compared to a matched control group (n=25).
Main Results:
- Bilateral hippocampal volume increases observed in two patients with the best clinical response.
- Mean hippocampal atrophy was significantly slower in the DBS group versus controls.
- DBS-associated volume changes correlated with metabolism and circuit-wide effects, with local volume expansions in AD-atrophied regions.
Conclusions:
- First in-human evidence suggests DBS may influence the course of brain atrophy in neurodegenerative diseases.
- Fornix DBS shows potential beyond modulating neural activity, possibly impacting neurodegenerative progression.
Related Concept Videos
Brain Imaging
998
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
998
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K

